Latest News

Orchid Pharma Q2 FY25 PAT up 26% YoY driven by strategic initiatives for market expansion

USFDA classifies Biocon Biologics’ Biocon Park in Bengaluru as VAI

Akums Drugs and Pharmaceuticals posts Q2 FY25 adjusted PAT at Rs. 66.7 Cr

Alembic receives USFDA final approval for Diltiazem Hydrochloride ER capsules

Zydus Wellness Q2 FY25 sales up 12% at Rs. 490.7 Cr

Aurobindo Pharma Q2 FY25 net profit up 8.6% at Rs. 817 Cr

Henkel, Covestro and Quad Industries collaborate for advanced medical wearables based on printed electronics

Fortis Healthcare Q2 FY25 PAT up 5% at Rs. 193 Cr

Vimta Labs reports Q2 FY25 PAT at Rs. 17 Cr

Granules India’s Unit V facility secures USFDA EIR with NAI status

Top News

trending-news

Startup

Pfizer INDovation program boosts six start-ups with Rs. 1.5 crore grant

The program aims to accelerate the development of 6 Indian innovations to improve ease of access to diagnostics and treatment monitoring

Policy

MRP of anti-cancer drugs to come down due to custom duty exemption and GST rate reduction

MRP of anti-cancer drugs to come down due to custom duty exemption and GST rate reduction

Health Minister Nadda inaugurates Medicine Update BJMFCON 2024

Health Minister Nadda inaugurates Medicine Update BJMFCON 2024

CDSCO, NRAI meets WHO international standards for vaccine regulations

CDSCO, NRAI meets WHO international standards for vaccine regulations

Opinion

Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA

Indian API companies to grow by 7-8% and operating profit margin to improve to 12-14% in FY2025: ICRA

Urgent need to redefine pharma companies’ role on several issues of the industry: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad

Urgent need to redefine pharma companies’ role on several issues of the industry: Dr. K. Nagaiah, Chief Scientist, CSIR - IICT, Hyderabad

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

Defending Public Health: Strategies to safeguard pharmaceutical quality: Raheel Shah, Business Development Director, BDR Pharmaceuticals

Digitization

Mastek partners Innovaccer to transform value-based care and improve patient experience

Mastek partners Innovaccer to transform value-based care and improve patient experience

Chemify gets grant to design and discover new drug leads for Tuberculosis and Malaria

Chemify gets grant to design and discover new drug leads for Tuberculosis and Malaria

NHA and IIT Kanpur sign MoU for development of digital public goods for AI in healthcare

NHA and IIT Kanpur sign MoU for development of digital public goods for AI in healthcare

Interviews

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

Capex commitment likely to be in the range of Rs. 200-300 Cr: Dr. R. Ananthanarayanan, CEO, Sajjan India

The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners

The focus in FY 23 for most players would be international markets and ROW exports: Ankit Poddar, director, Candle Partners

We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India

We have built new AI platforms like REILI to meet current needs: Chander Shekhar Sibal, Sr. Vice-President, Fujifilm India

People

Imtiyaz Basade appointed Senio

Imtiyaz Basade appointed Senior VP of NATCO Pharma

Jubilant Ingrevia appoints Vij

Jubilant Ingrevia appoints Vijay Srivastava as Chief of Operations

Lupin appoints Claus Jepsen as

Lupin appoints Claus Jepsen as President, Global Specialty

Drug Approvals

Alembic receives USFDA final approval for Diltiazem Hydrochloride ER capsules

Alembic receives USFDA final approval for Diltiazem Hydrochloride ER capsules

Granules India’s Unit V facility secures USFDA EIR with NAI status

Granules India’s Unit V facility secures USFDA EIR with NAI status

Lupin receives tentative approval from USFDA for Raltegravir Tablets

Lupin receives tentative approval from USFDA for Raltegravir Tablets

Healthcare

Medanta to operate and manage 750 bed super speciality hospital in Pitampura, New Delhi

Medanta to operate and manage 750 bed super speciality hospital in Pitampura, New Delhi

KIMS to acquire 3,000 beds in next 5 years in Kerala

KIMS to acquire 3,000 beds in next 5 years in Kerala

WHO declares India has eliminated Trachoma as a public health problem in 2024

WHO declares India has eliminated Trachoma as a public health problem in 2024

Supply Chain

DKSH partners with R-Biomeds to bring oncology and thyroid treatments to Cambodia

DKSH partners with R-Biomeds to bring oncology and thyroid treatments to Cambodia

Lupin signs distribution agreement with Celnova for orphan drug NaMuscla

Lupin signs distribution agreement with Celnova for orphan drug NaMuscla

DKSH partners with Hasten Biopharmaceutical’s growth in Thailand

White Papers

Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants

Implementing a digital transformation in chemical operations to maximize profitability

The complexity of compliance

The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation

The guiding role of fluidized and spouted bed technologies in particle building processes